Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Krebs

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Cytotherapy|June 10, 2014
Cell carriers to attack gliomaSimone Krebs, Stephen Gottschalk
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 8, 2009
Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trialSimone Krebs, Talib N Omer, Bilal Omer
Clinical Nuclear Medicine|December 23, 2025
Genioglossus Muscle Uptake on 18F-FDG PET/CT, Secondary to Hypoglossal Nerve Stimulation: A Potential Oncologic Imaging PitfallAhmed Ebada Salem, Simone Krebs, Kathryn Morton
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2019
Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome PredictionSimone Krebs, Vladimir Ponomarev, Susan Slovin, et al.
Psychology & Health|June 17, 2020
Effects of a workplace physical activity intervention on cognitive determinants of physical activity: a randomized controlled trialSimone Krebs, Ramona Wurst, Wiebke Göhner, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2010
Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trialSimone Krebs, Bilal Omer, Talib Noor Omer, et al.
Frontiers in Oncology|January 16, 2014
Genetically modified T cells to target glioblastomaSimone Krebs, Tania G Rodríguez-Cruz, Christopher Derenzo, et al.
Clinical Nuclear Medicine|May 18, 2016
IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CTSimone Krebs, Serena Monti, Surya Seshan, et al.
Applied Psychology. Health and Well-Being|June 20, 2019
Effects of a Worksite Group Intervention to Promote Physical Activity and Health: The Role of Psychological CoachingSimone Krebs, Anke Baaken, Ramona Wurst, et al.
Clinical Nuclear Medicine|May 21, 2020
Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CTSimone Krebs, Iva Petkovska, Alan L Ho, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Cytotherapy|June 10, 2014
Cell carriers to attack gliomaSimone Krebs, Stephen Gottschalk
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 8, 2009
Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trialSimone Krebs, Talib N Omer, Bilal Omer
Clinical Nuclear Medicine|December 23, 2025
Genioglossus Muscle Uptake on 18F-FDG PET/CT, Secondary to Hypoglossal Nerve Stimulation: A Potential Oncologic Imaging PitfallAhmed Ebada Salem, Simone Krebs, Kathryn Morton
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2019
Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome PredictionSimone Krebs, Vladimir Ponomarev, Susan Slovin, et al.
Psychology & Health|June 17, 2020
Effects of a workplace physical activity intervention on cognitive determinants of physical activity: a randomized controlled trialSimone Krebs, Ramona Wurst, Wiebke Göhner, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 17, 2010
Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trialSimone Krebs, Bilal Omer, Talib Noor Omer, et al.
Frontiers in Oncology|January 16, 2014
Genetically modified T cells to target glioblastomaSimone Krebs, Tania G Rodríguez-Cruz, Christopher Derenzo, et al.
Clinical Nuclear Medicine|May 18, 2016
IgG4-Related Kidney Disease in a Patient With History of Breast Cancer: Findings on 18F-FDG PET/CTSimone Krebs, Serena Monti, Surya Seshan, et al.
Applied Psychology. Health and Well-Being|June 20, 2019
Effects of a Worksite Group Intervention to Promote Physical Activity and Health: The Role of Psychological CoachingSimone Krebs, Anke Baaken, Ramona Wurst, et al.
Clinical Nuclear Medicine|May 21, 2020
Laboratory-Proven Asymptomatic SARS-CoV-2 (COVID-19) Infection on 18F-FDG PET/CTSimone Krebs, Iva Petkovska, Alan L Ho, et al.
Pageof 6